GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.
We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
Eisai is derived from the Japanese word for ‘health product’ and, here at Eisai, we discover, develop and market innovative, high-quality medicines throughout the world.
In Australia and New Zealand, Neurology and Oncology are our primary specialty areas.
For more information about Eisai, or our products, please choose one of the following:
For Australia: visit www.eisai.com.au or email Contact_Australia@eisai.net
For New Zealand: visit www.eisai.co.nz or email Contact_NewZealand@eisai.net
Building on 125 years of research, innovation and care, Nutricia pioneers medical nutrition that helps enable life-changing and life-saving health outcomes, so that people can live their life to its fullest.
Nutricia supports healthy growth and development in early life and plays its part addressing some of the world’s biggest health challenges from birth through to old age. The Nutricia portfolio includes a wide range of nutritional solutions for pre-term birth, faltering growth, food allergy, rare metabolic diseases, age-related conditions and chronic disease, such as frailty, cancer, stroke and early Alzheimer’s disease.
As part of Danone, Nutricia embraces the company’s “One Planet. One Health” frame of action reflecting that the health of people and the health of the planet are interconnected and therefore seeks to protect and nourish both.
Souvenaid, launched in 2013 in Australia, is a medical drink formulated to nutritionally support memory function in patients with early Alzheimer’s Disease when taken daily for at least 6 months. Over time, Alzheimer’s disease causes a loss of synapses or connections in the brain. Souvenaid contains a unique combination of nutrients formulated to support the growth of brain connections. Backed by 20 years of research, Souvenaid is proven to slow memory and cognitive decline by 60% in an early stage of Alzheimer’s disease known as mild cognitive impairment when taken daily for 3 years.
STADA Australia is a speciality prescription pharmaceutical and consumer healthcare company.
Part of a global group, STADA Arzneimittel AG, the company sells its products in approximately 120 countries worldwide.
Since 2016, STADA has provided prescription products in Australia and New Zealand, for both chronic and serious medical conditions, with a particular focus on the treatment of Parkinson’s disease. The STADA Nurse Advisor Service has supported this work by partnering with all relevant healthcare professionals, providing a high-quality service for patients and their families.
Building on this success, STADA Australia is currently expanding into new therapeutic areas with a clear purpose of caring for people‘s health as a trusted partner.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Professional support to become the best doctor you can be.
Medical Protection helps you avoid risks throughout your whole career.
Medical Protection is about more than just providing indemnity. We have helped thousands of members with a wide range of professional queries.
Our advisers are experienced medical doctors in New Zealand who understand what it is like to practice medicine in the real world. They are available 24 hours a day to help and advise you for any emergency matters
Established in 1986, the CGM Research Trust (based in Christchurch) is a charitable organisation committed to the enhancement of research and quality health care. We are a Clinical Research Facility for medicines, medical and surgical treatment. Our dedicated facility provides patient-centred studies and trials coordinated by our clinical specialised medical team, consisting of specialised Physicians and experienced dedicated Registered Nurses.
We are a leader in clinical research trials services, consultancy, and patient education, working with pharmaceutical and medical research organisations in New Zealand and around the world.
Our expertise in medical research focusses on improving outcomes for people with conditions where there is an unmet need.